Welcome to our dedicated page for Nova SEC filings (Ticker: NVMI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Nova Ltd. filings document its foreign private issuer reporting for a semiconductor metrology and process control company. Form 6-K current reports incorporate press releases on financial results, scheduled earnings releases, investor conference participation, product adoption for Nova Metrion®, and other operating updates. The Form 20-F annual report includes audited consolidated financial statements and establishes the company's reporting framework under Form 20-F rather than Form 40-F.
The filing record also identifies Nova's Nasdaq ticker NVMI and TASE trading status. Current reports preserve formal notices for annual-report availability, scheduled conference calls and public communications made under Exchange Act Rule 13a-16 or 15d-16.
NOVA LTD. director Sarit Sagiv filed an initial ownership report on Form 3 showing direct holdings of ordinary shares tied to multiple restricted share unit (RSU) awards. The reported positions represent ordinary shares issuable upon vesting of RSUs granted on June 23, 2022, May 18, 2023, June 20, 2024 and June 18, 2025. The 2022, 2023 and 2024 RSU grants each vest in four equal annual installments of 25% on every anniversary of the grant date, while the 2025 grant vests 100% on its first anniversary. The filing does not show any buy or sell transactions, only these RSU-based holdings.
Nova Ltd. director Hadar Rami filed an initial ownership report showing rights to 758 ordinary shares through restricted share units. These RSUs were granted on December 24, 2025 and vest annually over three years, subject to continued service. The filing does not report any share purchases or sales, only existing equity-based compensation.
NOVA LTD. director Cohen Raanan filed an initial ownership report outlining his equity position in the company. The filing lists direct holdings of ordinary shares and equity awards rather than new purchases or sales.
He holds options to acquire 960 ordinary shares at an exercise price of $102.35 per share, which became fully exercisable on June 24, 2025 and expire on June 24, 2027. The report also describes several blocks of ordinary shares that are issuable upon vesting of restricted share units granted on June 23, 2022, May 18, 2023, June 20, 2024, and June 18, 2025. For the 2022–2024 grants, 25% of the RSUs vest on each anniversary of the grant date, while the 2025 grant vests 100% on the first anniversary.
NOVA LTD. Chief Financial Officer Guy Kizner has filed a Form 3 reporting his initial beneficial ownership of ordinary shares. The filing shows direct holdings along with multiple restricted share unit (RSU) awards that each vest 25% on every anniversary of their grant dates from November 2022 through September 2025.
NOVA LTD. filed an initial insider ownership report for CEO and president Gabriel Waisman. The Form 3 lists his direct holdings of ordinary shares along with several grants of restricted share units (RSUs).
The RSUs were granted on September 1, 2022, June 1, 2023, July 1, 2024, and July 1, 2025. For each grant, 25% of the RSUs vest on every anniversary of the grant date, and ordinary shares are issuable upon vesting and settlement of an equivalent number of RSUs. The filing does not show new purchases or sales, but instead establishes Waisman’s starting equity position and time-based vesting schedule as an executive of the company.
Nova Ltd. director Oppenhaim Eitan filed a Form 3 as an initial statement of beneficial ownership of the company’s ordinary shares. The filing lists several direct holdings, with individual blocks including 3,008 ordinary shares, 2,586 ordinary shares, 1,932 ordinary shares, and 646 ordinary shares.
Footnotes clarify that these positions represent ordinary shares issuable upon vesting and settlement of restricted share units granted on May 18, 2023, June 20, 2024, and June 18, 2025. The 2023 and 2024 grants vest 25% on each anniversary of the grant date, while the 2025 grant vests 100% on the first anniversary. The document records existing equity awards rather than new open-market purchases or sales.
NOVA LTD. director Avi Cohen has filed an initial statement of beneficial ownership. The filing reports direct holdings of Ordinary Shares and vested stock options in NOVA LTD.
The holdings include Ordinary Shares, with one line showing 5,057 shares held directly, and vested options over 2,090 Ordinary Shares at an exercise price of $48.2000 per share expiring on June 24, 2027, and options over 960 Ordinary Shares at $102.3500 per share expiring on June 27, 2028.
Footnotes state that the options became fully exercisable on June 25, 2024 and June 24, 2025, and that several reported positions represent Ordinary Shares issuable upon vesting of restricted share units that vest in annual installments following their respective grant dates.
Nova Ltd. filed a Form 6-K to share a press release announcing that its Chief Financial Officer, Guy Kizner, will participate in upcoming investor conferences, including fireside chats hosted by Morgan Stanley and Cantor. Live webcasts of these sessions will be accessible through Nova’s investor relations website, and management will also hold one-on-one investor meetings arranged via banking representatives.
The company highlights its role as a leading provider of material, optical and chemical metrology solutions that help semiconductor manufacturers control advanced production processes, improve yields and shorten time to market. The release also includes forward-looking statements about anticipated growth opportunities and outlines a wide range of business risks, including geopolitical, technological, supply-chain and market uncertainties that could cause actual results to differ from expectations.
An affiliated holder of NVMI has filed a notice of proposed sale under Rule 144 for 3,125 ordinary shares, with an aggregate market value of 1,386,750.00. Shares outstanding were 31,780,111, and the approximate sale date is February 17, 2026 on Nasdaq.
The shares to be sold were originally acquired through restricted stock unit (RSU) grants from the issuer on September 1, 2021 (6,500 securities) and September 1, 2022 (4,500 securities), with no cash payment required at acquisition.
Nova Measuring Instruments ordinary shares are being prepared for sale under Rule 144. A holder has filed to potentially sell 9,346 ordinary shares through Oppenheimer & Co. on Nasdaq, with an aggregate market value of $4,147,380.96 and 31,780,111 shares outstanding.
The shares to be sold were originally acquired as restricted stock units from the issuer in two grants: 4,466 shares on 09/01/2017 and 4,880 shares on 09/01/2018, both fully paid via RSU awards rather than cash.